Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Microcap & Penny Stocks : Pharmos(PARS) -- Ignore unavailable to you. Want to Upgrade?

To: NeuroInvestment who wrote (698)	5/3/1998 10:27:00 PM
From: Ariella	Respond to of 1491

Thank you very much for the update on HU-211. The thread needed some new info to discuss ;-) Regards, Ariella

To: NeuroInvestment who wrote (698)	5/3/1998 11:12:00 PM
From: yosi s	Read Replies (3) \| Respond to of 1491

I spoke with PARS within the last 10 days, agree that third group started enrolling. Also first 2 cohorts are completed, there is some long term follow up 3 months for the last enrolle in the second cohort. They will unblind the study once the first 2 chorts are fully completed. They will not wait to unblind the study for the third cohort. Once the first 2 chorts are unblinded with that infi they will negotiate for terms with fututre partner. So they need that info to proceede. expect that in mid to late summer. In the interim price pressure to be expected. In view of activity on this thread Guess PARS will open much higher and will soon be back to 3$.and will trade 3-4$ in second half of May.